Clinical Trials Browser

Phase EARLY_PHASE1 × Unknown × Lymphoid × Clear all

NCT05838599 2024-03-12

Combining Topical Imiquimod With Local Radiotherapy for Treatment of Mycosis Fungoides

Phase EARLY_PHASE1 Unknown

Mycosis Fungoides

NCT06277011 2024-02-26

Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of Relapsed and/or Refractory CD19-positive B Cell Hematological Malignancies Clinical Research

Phase EARLY_PHASE1 Unknown

LymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05747157 2023-11-21

Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10- 19) in the Treatment of r/r B-ALL Clinical Research

Phase EARLY_PHASE1 Unknown

Burkitt Lymphoma

NCT06045585 2023-09-21

JY231 Injection in the Treatment of Relapsed or Refractory B-cell Lymphoma

Phase EARLY_PHASE1 Unknown

Lymphoma, Recurrence, Lymphoma, B-Cell

NCT04504526 2023-09-15

Value of Chemokine Receptor CXCR4 Imaging for Diagnosis and Prognostic Evaluation in Lymphoproliferative Diseases

Phase EARLY_PHASE1 Unknown

LymphoidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Multiple Myeloma

NCT05673447 2023-08-28

The Study of Anti-CD19 CAR NK Cells in the Treatment of Relapsed/Refractory Diffuse Large B Cell Lymphoma

Phase EARLY_PHASE1 Unknown

Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT05979792 2023-08-21

Clinical Study of CD7 CAR-T Cell Injection in the Treatment of Patients With Relapsed or Refractory CD7-positive Peripheral T Cell Lymphoma

Phase EARLY_PHASE1 Unknown

Lymphoma, T-Cell, Peripheral

NCT05715606 2023-07-05

Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of r/r DLBCL Clinical Research

Phase EARLY_PHASE1 Unknown

Lymphoma, Large B-Cell, Diffuse

NCT05105867 2023-05-10

CD19 Targeted Universal Chimeric Antigen Receptor T Cells Injection for CD19+ Refractory/Relapsed B-cell Malignancies

Phase EARLY_PHASE1 Unknown

Burkitt Lymphoma, Recurrence, Lymphoma, B-Cell

NCT05739227 2023-02-22

Safety and Efficacy of Allogenic CD19-CAR-NK Cells in Treatmenting r/r B-cell Hematologic Malignancies

Phase EARLY_PHASE1 Unknown

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05651191 2022-12-14

To Evaluate the Safety and Efficacy of Human CD19 Targeted DASH CAR-T Cells Injection for Subjects With R/R B-ALL

Phase EARLY_PHASE1 Unknown

Burkitt Lymphoma

NCT05013372 2022-08-02

CD147-CAR T Cells for Relapsed/Refractory T Cell Non-Hodgkin's Lymphoma

Phase EARLY_PHASE1 Unknown

Lymphoma, T-Cell

NCT05480501 2022-07-29

Clinical Trial to Evaluate the Safety and Efficacy of IM19 CAR-T Cells in Patients With Relapsed and Refractory (R/R) B-cell Acute Lymphoblastic Leukemia

Phase EARLY_PHASE1 Unknown

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Leukemia

NCT05444322 2022-07-11

A Study of RD14-01 in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma

Phase EARLY_PHASE1 Unknown

Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

NCT05277987 2022-03-14

An Evaluation Trial About Anti-claudin18.2 the Specificity of Chimeric Antigen Receptor T Cells in the Advanced Gastric / Esophagogastric Junction Adenocarcinoma and Pancreatic Cancer Subjects

Phase EARLY_PHASE1 Unknown

CAR T-Cell Therapy

NCT05239676 2022-02-15

Autologous Hematopoietic Stem Cell Transplantation Combined With CAR-T Cells in the Treatment of Refractory and Relapsed Malignant Lymphoma

Phase EARLY_PHASE1 Unknown

Lymphoma

NCT05208853 2022-01-26

An Exploratory Clinical Study Evaluating the Safety and Efficacy of Anti CD30 CAR T Cells in Patients With CD30+ Relapsed/Refractory Lymphoma

Phase EARLY_PHASE1 Unknown

Hodgkin Disease, Immunoblastic Lymphadenopathy, Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Extranodal NK-T-Cell

NCT04264078 2021-06-28

Anti-CD7 U-CAR-T Cell Therapy for T/NK Cell Hematologic Malignancies

Phase EARLY_PHASE1 Unknown

LymphoidOther hematologic neoplasm

Leukemia, T-Cell, Lymphoma, T-Cell

NCT04767308 2021-02-23

Safety and Efficacy of CT125A Cells for Treatment of Relapsed/Refractory CD5+ Hematopoietic Malignancies

Phase EARLY_PHASE1 Unknown

LymphoidOther hematologic neoplasm

Lymphoma, Follicular, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Peripheral, Hematologic Neoplasms, Lymphoma, Mantle-Cell

NCT04439721 2021-01-06

γδT

Phase EARLY_PHASE1 Unknown

LymphoidOther hematologic neoplasm

Leukemia, Leukemia, B-Cell

NCT04696705 2021-01-06

Allogeneic γδ T Cells Immunotherapy in r/r Non-Hodgkin's Lymphoma (NHL) or Peripheral T Cell Lymphomas (PTCL) Patients

Phase EARLY_PHASE1 Unknown

Lymphoma, Non-Hodgkin, Lymphoma, T-Cell, Peripheral

NCT04638270 2020-11-20

Anti-CD19 FasT CAR-T Cell Therapy for B Cell NHL

Phase EARLY_PHASE1 Unknown

Lymphoma, Non-Hodgkin

NCT04626726 2020-11-13

Adult B-ALL Treated by CART Cell Bridging Allogeneic Hematopoietic Stem Cell Transplantation

Phase EARLY_PHASE1 Unknown

Burkitt Lymphoma

NCT04626765 2020-11-13

CAR-T for Children With Relapsed and Refractory Acute Lymphoblastic Leukemia

Phase EARLY_PHASE1 Unknown

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04412174 2020-06-02

A Study of GC022F CAR-T Cell Immunotherapy for Relapsed or Refractory B- NHL

Phase EARLY_PHASE1 Unknown

Lymphoma, B-Cell

NCT04129099 2020-05-28

A Study of GC022F CAR-T Cell Immunotherapy for Relapsed or Refractory B- ALL

Phase EARLY_PHASE1 Unknown

Burkitt Lymphoma

NCT03790891 2020-03-13

Treatment of Non-Hodgkin Lymphoma With CD19-TriCAR-T/SILK Cell Therapy

Phase EARLY_PHASE1 Unknown

Lymphoma, Non-Hodgkin

NCT04226989 2020-02-21

A Study of CT-RD06 Cell Injection in Patients With Relapsed or Refractory CD19+ B-cell Hematological Malignancy

Phase EARLY_PHASE1 Unknown

LymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04264039 2020-02-11

Anti-CD19 U-CAR-T Cell Therapy for B Cell Hematologic Malignancies

Phase EARLY_PHASE1 Unknown

Burkitt Lymphoma, Lymphoma, B-Cell

NCT03436342 2019-12-27

Chemokine Receptor CXCR4-targeting Molecular Imaging for Metabolic Characterization of Multiple Myeloma and Lymphoma

Phase EARLY_PHASE1 Unknown

LymphoidPlasma cell

Lymphoma, Multiple Myeloma

NCT04191941 2019-12-10

Treatment of Hematological Malignancy With Novel CAR-T Cells.

Phase EARLY_PHASE1 Unknown

LymphoidPlasma cell

Burkitt Lymphoma, Multiple Myeloma, Lymphoma, B-Cell

NCT04184414 2019-12-03

The Clinical Application of Chimeric Antigen Receptor T Cells in the Treatment of CD19 Positive Recurrent Refractory B Cell-derived Hematological Malignancies

Phase EARLY_PHASE1 Unknown

Burkitt Lymphoma, Lymphoma, Follicular, Lymphoma, Mantle-Cell

NCT04169932 2019-11-20

The Clinical Study of CD20 CAR-T Cells in Patients With Relapsed and Refractory B Cell Non-Hodgkin Lymphoma

Phase EARLY_PHASE1 Unknown

Lymphoma, Non-Hodgkin, Recurrence, Lymphoma, B-Cell

NCT04166838 2019-11-18

The Clinical Study of CD19 UCAR-T Cells in Patients With B-cell Acute Lymphoblastic Leukemia (B-ALL)

Phase EARLY_PHASE1 Unknown

Burkitt Lymphoma

NCT04156178 2019-11-12

CD20-CD19 Compound CAR (cCAR) T Cells for Patients With Relapsed /Refractory B Cell Malignancies

Phase EARLY_PHASE1 Unknown

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Leukemia, B-Cell, Lymphoma, B-Cell

NCT04156243 2019-11-12

CD19 CARvac T Cells for Patients With Relapsed / Refractory B Cell Malignancies

Phase EARLY_PHASE1 Unknown

LymphoidOther hematologic neoplasm

Leukemia, B-Cell, Lymphoma, B-Cell

NCT04106336 2019-09-27

Cortical Excitability and Role of rTMS in Cannabis Use Disorder

Phase EARLY_PHASE1 Unknown

Lymphoma, Follicular

NCT04028440 2019-09-26

γδT Cells Immunotherapy in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)

Phase EARLY_PHASE1 Unknown

LymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Lymphoma, T-Cell, Peripheral

NCT03910842 2019-09-06

Treatment of Children CD19+ Leukemia and Non-Hodgkin Lymphoma With CD19-TriCAR-T/SILK Cell Therapy

Phase EARLY_PHASE1 Unknown

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Non-Hodgkin

NCT03116659 2019-08-13

CTCL Directed Therapy

Phase EARLY_PHASE1 Unknown

DermatologicLymphoid

Lymphoma, T-Cell, Cutaneous

NCT03690310 2019-01-31

Study of Anti-CD19 CAR NK Cells in Relapsed and Refractory B Cell Lymphoma

Phase EARLY_PHASE1 Unknown

Lymphoma, B-Cell

NCT03824951 2019-01-31

Study of Anti-CD19 iCAR NK Cells in Relapsed and Refractory B Cell Lymphoma

Phase EARLY_PHASE1 Unknown

Lymphoma, B-Cell

NCT03824964 2019-01-31

Study of Anti-CD19/CD22 CAR NK Cells in Relapsed and Refractory B Cell Lymphoma

Phase EARLY_PHASE1 Unknown

Lymphoma, B-Cell

NCT03825731 2019-01-31

A Study of GC022 CAR-T Cell Immunotherapy for Relapsed or Refractory B- ALL

Phase EARLY_PHASE1 Unknown

Burkitt Lymphoma

NCT03692767 2019-01-30

Study of Anti-CD22 CAR NK Cells in Relapsed and Refractory B Cell Lymphoma

Phase EARLY_PHASE1 Unknown

Lymphoma, B-Cell

NCT03642496 2018-08-23

Clinical Study of ET019002-T Cell Therapy for Refractory/Relapsed B-Cell Malignancies

Phase EARLY_PHASE1 Unknown

B-Cell Malignancies